We strongly encourage patients to have a comprehensive eye exam before beginning semaglutide therapy
The Risks of Trying GLP-1 Microdosing Without Medical Guidance GLP-1 microdosing may be discussed as a lower-intensity option, but trying it without clinical oversight can increase risk
Ipamorelin is a synthetic five-residue pentapeptide that acts as a selective agonist at the growth-hormone-secretagogue receptor type 1a (GHSR-1a) the same receptor through which the endogenous hormone ghrelin signals, triggering a phospholipase C cascade
Begin by opening the vial of Semaglutide or Tirzepatide and removing the needle cap
Source: Sciencedirect Of particular importance is that GLP-1 receptor activation inhibits cell death pathways, reduces inflammation, reduces oxidative stress, and increases neurotransmitter release
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Torne CW, Ryan DH (2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
